A study published today in the New England Journal of Medicine found that e-cigarettes are almost twice as effective as NRT to help smokers remain abstinent from cigarettes.
The study team, from Queen Mary University of London, saw that 18% of participants who received vaping products and a four-week course of behavior remained abstinent after a year, against 10% of those the medical data such as nicotine patches or gum. Participants received a start-vaping kit and advised to take their own future purchasing decisions.
Previous studies e-cigarette using the “gold standard” randomized controlled methodology were conducted years ago on the basis of one (no longer available) e-cigarette model, which was poor to deliver the nicotine. Even still, these studies showed a modest level of efficiency, almost equal to that of spots and gums. The lack of an obvious advantage, however, has long medical professionals to lead to be skeptical about the need for more vaping products, existing, medicinal treatments.
The vaping technology has developed considerably since the original studies and consumers now have access to a wide range of products. The Queen Mary valid study is unique in that they allowed their participants to try different products to find out what suits them. Unfortunately, vaping products in the EU are hampered by regulations limiting the size of the cartridge and the power of nicotine. The limits have been imposed to avoid problems of toxicity or overdose and were based on inaccurate assessments of the toxicity of nicotine. Countries without such restrictions have not seen problems with vaping products commonly available.
In light of these makers of the study will be challenged to assess the probability may be higher if these restrictions were relaxed efficient e-cigarette. An indication that this might be true is that the participants evaluated the products as being more satisfying than NRT, but less satisfactory than cigarettes. They probably do not get enough nicotine each puff, given the strength limits. The small dimensions and tank cartridges can be a “hassle factor” – a consumer pain point which makes them more difficult to use products.
“One issue that is rarely discussed is that some smokers actually enjoy smoking”
Doctors have been reluctant to recommend products vaping smoking patients, largely because previous studies have shown little benefit over existing therapies NRT. study author Peter Hajek suggested that this reluctance is now “likely to change” in the light of the results. But to what extent is the “seal of approval” the main obstacle holding medical smoking transition back even more?
E-cigarettes had their debut as consumer products rather than medical interventions. Although this study provides good data on what happens when the middle-aged smokers are encouraged to try the contemporary vaping products, it can not tell the greatest story on how vaping affects all behaviors smoking.
The technology is quite unique in that it was initiated by vibrant user communities and online entrepreneurs commercialized innovations. The reason that many people who smoke are successful with vaping products is simple: they are designed to be enjoyable. As author of the study, Hayden McRobbie said, “an issue that is rarely discussed is that some smokers actually enjoy smoking and vaping can help them keep this.”
NRT, with its positioning and medical characteristics dour, was never liked by smokers. Perhaps the key to ending smoking is this simple: Leave nicotine treated like any consumer product, and enable companies to develop products that love smoking.
Learn more about what is vaping?